Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SDHB | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | ITGB1BP2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | USP28 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | RP11-211G3.2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | GBA | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | ZNF608 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | FAM65A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | PSMB4 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | EMILIN3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | MTA1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |